Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of...
Reexamination Certificate
2005-09-20
2005-09-20
Ungar, Susan (Department: 1642)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
C435S326000, C435S320100, C536S023100, C536S023500
Reexamination Certificate
active
06946289
ABSTRACT:
The invention relates to nucleic acid molecules which code for the tumor rejection antigen precursor MAGE-6. Also disclosed are vectors, cell lines, and so forth, which utilize the nucleic acid molecule, and optionally, molecules coding for human leukocyte antigen HLA-A1. Use of these materials in therapeutic and diagnostic contexts are also a part of the invention.
REFERENCES:
patent: 4786719 (1988-11-01), Kudo et al.
patent: 5405940 (1995-04-01), Boon et al.
patent: 6488932 (2002-12-01), Boon et al.
Drexler et al. Leukemia and Lymphoma, 1993, 9:1-25.
Embleton et al. Immunol Ser, 1984, 23:181-207.
Hsu et al. In:Tissue Culture Methods and Applications, Kruse and Patterson, Eds, 1973, Academic Press, NY, see abstract, p.764.
Freshney et al. Culture of Animal Cells, A Manual of Basic Technique, Alan R. Liss, Inc., 1983, New York, p4.
Dermer et al. Bio/Technology, 1994, 12:230.
Ezzell et al. J. NIH Res, 1995, 7:46-49.
Spitler et al. Cancer Biotherapy, 1995, 10:1-3.
Boon et al. Adv Can Res, 1992, 58:177-210.
Harris et al. J. of The Am Society of Nephrology 6:1125-33, 1995.
Ahn et al. Nature Genetics 3(4):283-91, 1993.
Cawthon et al. Genomics 9(3):446-60, 1991.
Jansen, M et al, 1995, Pediatric Res, 37 (6): 681-686.
Alberts et al. Molecular Biology of the Cell, 3rd edition, 1994, p. 465.
Shantz and Pegg. Int J of Biochem and Cell Biol., 1999, vol. 31, pp. 107-122.
McClean and Hill (Eur J of Cancer, 1993, vol. 29A, pp. 2243-2248.
Fu et al (EMBO Journal, 1996, vol. 15, pp. 4392-4401.
Yokota, J et al (Oncogene, 1988, vol. 3, pp. 471-475.
Roitt et al, (Eds) Immunology, 4th ed, 1998, p. 7.9.
Roitt, I et al, 1998, Immunology, 4th ed, Mosby, London, pp. 7.10-7.11.
Burgess et al. Journal of Cell Biology, 1990, 11: 2129-2138.
Lazar et al. Molecular and Cell Biology, 1988, 8: 1247-1252.
Tao. et al. The Journal of Immunology, 1989, 143(8): 2595-2601.
Gillies et al. Human Antibodies and Hybridomas, 1990, 1(1): 47-54.
Kirkin, AF et al, 1998, APMIS 106: 665-679.
Harris et al. J. of The Am Society of Nephrology 6:1125-33, 1995.
Ahn et al. Nature Genetics 3(4):283-91, 1993.
Cawthon et al. Genomics 9(3):446-60, 1991.
Bowie et al (Science, 1990, 257: 1306-1310).
De Plaen, E, 1994, Immunogenetics, 40: 360-369.
Roitt I et al, 1998, Immunology, 4th ed, Mosby, London, p. 7.9.
Chaux, P et al, 1998, Intl J Cancer, 77: 538-542.
Ezzell (J. NIH Res, 1995, 7:46-49).
Spitler (Cancer Biotherapy, 1995, 10:1-3).
Boon (Adv Can Res, 1992, 58:177-210).
Gura (Science, 1997, 278:1041-1042).
Jain (Sci. Am., 1994, 271:58-65).
Curti (Crit. Rev. in Oncology/Hematology, 1993, 14:29-39).
Hartwell et al (Science, 1997, 278:1064-1068).
Boon-Falleur Thierry
Guagler Béatrice
van den Eynde Benoit
van der Bruggen Pierre
Davis Minh-Tam
Fulbright & Jaworski LLP
Ludwig Institute for Cancer Research
Ungar Susan
LandOfFree
Isolated nucleic acid molecules coding for tumor rejection... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isolated nucleic acid molecules coding for tumor rejection..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isolated nucleic acid molecules coding for tumor rejection... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3373515